Skip to main content
. 2021 Dec 7;11(12):1842. doi: 10.3390/biom11121842

Figure 3.

Figure 3

PLOD2 spatial expression in different cell types of OSCC patients. (a) Representative immunohistochemistry (IHC) staining of PLOD2 in tumor cells (TCs), fibroblast-like cells (FLCs), and tumor-infiltrating lymphocytes (TILs). (b) Representative high and low expression of PLOD2 in FLCs and TCs. *** p < 0.001.